Effect of Delayed vs Immediate Stent Implantation on Myocardial Perfusion and Cardiac Function in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention With Thrombus Aspiration

Canadian Journal of Cardiology

Volumn 27, Issue 5, 2011, Pages 541-547

  Tang, Liang ^a   Zhou, Sheng hua ^a   Hu, Xin qun ^a   Fang, Zhen fei ^a   Shen, Xiang qian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TIROFIBAN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD CLOT LYSIS; CLINICAL ASSESSMENT; DELAYED STENT IMPLANTATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FUNCTION; HEART MUSCLE PERFUSION; HOSPITAL ADMISSION; HUMAN; IMMEDIATE STENT IMPLANTATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT; THROMBUS ASPIRATION; TREATMENT DURATION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 81255165886     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2011.03.001     Document Type: Article

References (30)

1. Keeley E.C., Boura J.A., Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003, 361:13-20.
2. Morishima I., Sone T., Okumura K., et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000, 36:1202-1209.
3. Ndrepepa G., Tiroch K., Fusaro M., et al. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 2010, 55:2383-2389.
4. Ito H., Maruyama A., Iwakura K., et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996, 93:223-228.
5. Henriques J.P., Zijlstra F., Ottervanger J.P., et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 2002, 23:1112-1117.
6. Izgi A., Kirma C., Tanalp A.C., et al. Predictors and clinical significance of angiographically detected distal embolization after primary percutaneous coronary interventions. Coron Artery Dis 2007, 18:443-449.
7. Kirma C., Izgi A., Dundar C., et al. Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions: experience at a single center. Circ J 2008, 72:716-721.
8. Niccoli G., Burzotta F., Galiuto L., Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol 2009, 54:281-292.
9. De Luca G., Navarese E., Marino P. Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials. Eur Heart J 2009, 30:2705-2713.
10. Bavry A.A., Kumbhani D.J., Bhatt D.L. Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials. Eur Heart J 2008, 29:2989-3001.
11. Yip H.K., Wu C.J., Chang H.W., et al. Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes. Chest 2003, 124:962-968.
12. Gibson C.M., de Lemos J.A., Murphy S.A., et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation 2001, 103:2550-2554.
13. Silva-Orrego P., Colombo P., Bigi R., et al. Thrombus aspiration before primary angioplasty improves myocardial reperfusion in acute myocardial infarction: the DEAR-MI (Dethrombosis to Enhance Acute Reperfusion in Myocardial Infarction) study. J Am Coll Cardiol 2006, 48:1552-1559.
14. Bolognese L., Falsini G., Liistro F., et al. Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions. J Am Coll Cardiol 2006, 47:522-528.
15. van't Hof A.W., Liem A., Suryapranata H., et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation 1998, 97:2302-2306. Zwolle Myocardial Infarction Study Group.
16. Gibson C.M., Cannon C.P., Daley W.L., et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996, 93:879-888.
17. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
18. Roe M.T., Ohman E.M., Maas A.C., et al. Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. J Am Coll Cardiol 2001, 37:9-18.
19. Claeys M.J., Bosmans J., Veenstra L., et al. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. Circulation 1999, 99:1972-1977.
20. Rezkalla S.H., Kloner R.A. No-reflow phenomenon. Circulation 2002, 105:656-662.
21. Haeck J.D., Verouden N.J., Henriques J.P., Koch K.T. Current status of distal embolization in percutaneous coronary intervention: mechanical and pharmacological strategies. Future Cardiol 2009, 5:385-402.
22. Meneveau N., Seronde M.F., Descotes-Genon V., et al. Immediate versus delayed angioplasty in infarct-related arteries with TIMI III flow and ST segment recovery: a matched comparison in acute myocardial infarction patients. Clin Res Cardiol 2009, 98:257-264.
23. Cafri C., Svirsky R., Zelingher J., et al. Improved procedural results in coronary thrombosis are obtained with delayed percutaneous coronary interventions. J Invasive Cardiol 2004, 16:69-71.
24. Timurkaynak T., Arslan U., Balcioglu S., Turkoglu S. Long term tirofiban infusion before percutaneous coronary intervention in patients with angiographically massive intracoronary thrombus. Saudi Med J 2008, 29:42-47.
25. Shen J., Zhang Q., Zhang R.Y., et al. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Coron Artery Dis 2008, 19:271-277.
26. van't Hof A.W., Ten Berg J., Heestermans T., et al. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial. Lancet 2008, 372:537-546.
27. Calvert J.W., Lefer D.J. Statin therapy and myocardial no-reflow. Br J Pharmacol 2006, 149:229-231.
28. Iwakura K., Ito H., Kawano S., et al. Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction. Eur Heart J 2006, 27:534-539.
29. Hubacek J., Basran R.S., Shrive F.M., et al. Prognostic implications of C-reactive protein and troponin following percutaneous coronary intervention. Can J Cardiol 2009, 25:e42-e47.
30. Araszkiewicz A., Lesiak M., Grajek S., et al. Effect of microvascular reperfusion on prognosis and left ventricular function in anterior wall myocardial infarction treated with primary angioplasty. Int J Cardiol 2007, 114:183-187.